| Cancer Type | Regimen |
| Acute lymphoblastic leukemia | Use of growth factor varies according to protocol |
| Bladder cancer | Dose-dense MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) |
| Bone cancer | VAI (vincristine, doxorubicin or dactinomycin, ifosfamide) |
| VDC-IE (vincristine, doxorubicin or dactinomycin, and cyclophosphamide alternating with ifosfamide and etoposide) |
| Cisplatin, doxorubicin |
| VDC (vincristine, doxorubicin or dactinomycin, cyclophosphamide) |
| VIDE (vincristine, ifosfamide, doxorubicin or dactinomycin, etoposide) |
| Breast cancer | Dose-dense AC→T (doxorubicin, cyclophosphamide, paclitaxel) |
| Docetaxel, cyclophosphamide ± trastuzumab |
| TAC (docetaxel, doxorubicin, cyclophosphamide) |
| TC(H) (docetaxel, carboplatin, ± trastuzumab) |
| Colorectal cancer | FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, irinotecan) |
| Head and neck squamous cell carcinoma | TPF (docetaxel, cisplatin, fluorouracil) |
| Hodgkin lymphoma | A+AVD (brentuximab vedotin, doxorubicin, vinblastine, dacarbazine) |
| Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) |
| Kidney cancer | Doxorubicin, gemcitabine |
| Non-Hodgkin lymphoma | Dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin ± rituximab) |
| ICE (ifosfamide, carboplatin, etoposide ± rituximab) |
| Dose-dense CHOP-14 (cyclophosphamide, doxorubicin, vincristine, prednisone ± rituximab) |
| MINE (mesna, ifosfamide, mitoxantrone, etoposide ± rituximab) |
| ESHAP (etoposide, methylprednisolone, cisplatin, cytarabine ± rituximab) |
| Hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, dexamethasone, ± rituximab) |
| DHAP (dexamethasone, cisplatin, cytarabine ± rituximab) |
| Melanoma | Dacarbazine-based combinations (with: cisplatin, vinblastine, aldesleukin [IL-2], interferon alfa) |
| Multiple myeloma | DT-PACE (dexamethasone, thalidomide, cisplatin, doxorubicin, cyclophosphamide, etoposide ± bortezomib) |
| Ovarian cancer | Topotecan ± bevacizumab |
| Docetaxel |
| Pancreatic adenocarcinoma | FOLFIRINOX (fluorouracil, leucovorin, irinotecan, oxaliplatin) |
| Soft tissue sarcoma | MAID (mesna, doxorubicin, ifosfamide, dacarbazine) |
| Doxorubicin |
| Doxorubicin/ifosfamide |
| Small cell lung cancer | Topotecan |
| Testicular cancer | VeIP (vinblastine, ifosfamide, cisplatin) |
| VIP (etoposide, ifosfamide, cisplatin) |
| TIP (paclitaxel, ifosfamide, cisplatin) |